David Dietz, University at Buffalo (IMAGE)
Caption
Dietz is principal investigator on the $2 million NIDA grant, which has the potential to identify novel therapies for treating cocaine addiction.
Credit
Douglas Levere, University at Buffalo
Usage Restrictions
None
License
Licensed content